
71% of HFrEF patients remain on MRA therapy after 1 year! The study analyzed MRA usage in heart failure patients, finding that 71% continued treatment after one year. Discontinuation was more likely in patients with advanced kidney disease, hyperkalemia, and severe heart failure. Almost half of those who stopped reinitiated therapy within the following year. Understanding these dynamics can guide better treatment adherence and improve patient outcomes in heart failure management.
Like
Save
Share